|
Market Closed -
Swiss Exchange
18:31:48 04/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 129.58 CHF | -1.33% |
|
+4.72% | +18.23% |
| 01:37am | Novartis Pelacarsen Fails Phase III Cardiovascular Outcomes Trial | MT |
| 09-05 | Novartis Says Pelacarsen Heart Disease Drug Missed Primary Endpoint -- 2nd Update | DJ |
Chart: Technical Analysis
Swiss ExchangeCHF
| Markets | Quality | ||
|---|---|---|---|
NYSE
| NVS | Delayed | |
CBOE
| NVS | Real-time | |
Boerse Muenchen
| NOTA | Real-time | |
Tradegate
| NOTA | Real-time | |
Mexican S.E.
| NVS N | End-of-day quote | |
London S.E.
| 0K9E | Delayed | |
Deutsche Boerse AG
| NOTA | Delayed | |
Börse Stuttgart
| NOTA | Delayed | |
Swiss Exchange
| NOVN | Delayed | |
CBOE
| 0QLR | Real-time | |
London S.E.
| 0QLR | Delayed | |
Xetra
| NOT | Delayed | |
Tradegate
| NOT | Real-time | |
OTC Markets
| NVSEF | Delayed | |
Xetra
| NOT | End-of-day quote | |
Borsa Italiana
| 1NOVN | End-of-day quote | |
Deutsche Boerse AG
| NOT | Delayed | |
Deutsche Boerse AG
| NOT | End-of-day quote | |
Boerse Muenchen
| NOT | Real-time | |
Börse Stuttgart
| NOT | Delayed | |
Mexican S.E.
| NOVN N | End-of-day quote | |
CBOE
| Real-time | ||
Wiener Boerse
| NOVN | End-of-day quote | |
CBOE
| 0QLR | Real-time | |
Swiss Exchange
| NOVNEE | Delayed | |
Buenos Aires S.E.
| NVS | End-of-day quote | |
Buenos Aires S.E.
| NVSD | End-of-day quote | |
Sao Paulo
| N1VS34 | Delayed | |
Toronto S.E.
| NVS | Delayed | |
Deutsche Boerse AG
| NOT0 | Delayed | |
Deutsche Boerse AG
| NOT1 | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Neutral |
| Resistance | 131.32 | 131.32 | 130.5 |
| Spread/Res. | -1.33% | -1.33% | -0.70% |
| Spread/Supp. | +2.19% | +5.83% | +30.53% |
| Support | 126.8 | 122.44 | 99.27 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- NOVN Stock
- Charts Novartis AG
Select your edition
All financial news and data tailored to specific country editions

















